PROSTATE CANCER FOUNDATION-FUNDED RESEARCH IDENTIFIES PROMISING COMBINATION IMMUNOTHERAPY TREATMENT FOR ADVANCED PROSTATE CANCER

Study defines a mechanism by which prostate cancer cells evade the immune system and a possible new precision immunotherapy regimen that counters it in an aggressive form of advanced disease. LOS ANGELES, March 2, 2023 /PRNewswire/ — Immunotherapies have successfully treated many types…